SS
Spruce Street Capital LP
NEW YORK NY · SEC CIK 0002050194
$509.68M2026Q2 reported value
30Positions
70.2%Top 10 weight · largest 11.5%
3 / 3New / sold out
26Q126Q2
Top 10 holdings % of portfolio
2026Q2 top buys estimated at quarter-end value
IFRX New+$11.99M
ALKS Added+$11.84M
KNSA Added+$10.04M
ZLAB New+$5.30M
ACHV New+$4.81M
2026Q2 top sells estimated at quarter-end value
CENTESSA PHARMAC Sold out-$19.46M
KALVISTA PHARMAC Sold out-$18.07M
MAZE Sold out-$5.97M
DNTH Reduced-$1.80M
2026Q2 holdings click a header to sort
Export CSV 🔒| Ticker | Name | Value ▼ | Weight | Shares | Share change | Change | Est. flow | Action |
|---|---|---|---|---|---|---|---|---|
| KNSA | KINIKSA PHARMACEUTICALS INTL | $58.71M | 11.52% | 918,070 | 157,007 | 20.6% | $10.04M | Added |
| RLAY | RELAY THERAPEUTICS INC | $55.83M | 10.95% | 2,984,125 | 0 | 0.0% | — | Unchanged |
| LBRX | LB PHARMACEUTICALS INC | $44.66M | 8.76% | 1,376,159 | 0 | 0.0% | — | Unchanged |
| RLMD | RELMADA THERAPEUTICS INC | $44.23M | 8.68% | 6,391,328 | 129,214 | 2.1% | $894,161 | Added |
| ANRO | ALTO NEUROSCIENCE INC | $35.71M | 7.01% | 1,353,047 | 27,837 | 2.1% | $734,618 | Added |
| DNTH | DIANTHUS THERAPEUTICS INC | $34.59M | 6.79% | 354,816 | -18,458 | -4.9% | -$1.80M | Reduced |
| ALKS | ALKERMES PLC | $28.50M | 5.59% | 543,876 | 225,884 | 71.0% | $11.84M | Added |
| SVRA | SAVARA INC | $21.27M | 4.17% | 3,452,576 | 69,401 | 2.1% | $427,510 | Added |
| PCVX | VAXCYTE INC | $17.79M | 3.49% | 306,047 | 60,338 | 24.6% | $3.51M | Added |
| ELVN | ENLIVEN THERAPEUTICS INC | $16.70M | 3.28% | 329,006 | 0 | 0.0% | — | Unchanged |
| ENTA | ENANTA PHARMACEUTICALS INC | $15.87M | 3.11% | 1,088,731 | 156,133 | 16.7% | $2.28M | Added |
| CATX | PERSPECTIVE THERAPEUTICS INC | $12.60M | 2.47% | 3,693,931 | 1,066,824 | 40.6% | $3.64M | Added |
| IFRX | INFLARX NV | $11.99M | 2.35% | 5,352,198 | 5,352,198 | — | $11.99M | New |
| SRZN | SURROZEN INC | $11.21M | 2.20% | 432,040 | 0 | 0.0% | — | Unchanged |
| ALMS | ALUMIS INC | $11.05M | 2.17% | 392,574 | 0 | 0.0% | — | Unchanged |
| IPSC | CENTURY THERAPEUTICS INC | $9.94M | 1.95% | 4,059,054 | 0 | 0.0% | — | Unchanged |
| NERV | MINERVA NEUROSCIENCES INC | $9.19M | 1.80% | 1,655,500 | 0 | 0.0% | — | Unchanged |
| SABS | SAB BIOTHERAPEUTICS INC | $8.57M | 1.68% | 2,198,502 | 0 | 0.0% | — | Unchanged |
| — | AN2 THERAPEUTICS INC | $8.04M | 1.58% | 1,661,073 | 0 | 0.0% | — | Unchanged |
| ERAS | ERASCA INC | $7.74M | 1.52% | 422,543 | 0 | 0.0% | — | Unchanged |
| IKT | INHIBIKASE THERAPEUTICS INC | $7.27M | 1.43% | 3,581,603 | 0 | 0.0% | — | Unchanged |
| — | RESEARCH ALLIANCE CORP III | $5.35M | 1.05% | 500,000 | 500,000 | — | — | First reported |
| HLXC | HELIX ACQUISITION CORP III | $5.32M | 1.04% | 500,000 | 0 | 0.0% | — | Unchanged |
| ZLAB | ZAI LAB LTD | $5.30M | 1.04% | 279,110 | 279,110 | — | $5.30M | New |
| ACHV | ACHIEVE LIFE SCIENCE INC | $4.81M | 0.94% | 736,637 | 736,637 | — | $4.81M | New |
| LXEO | LEXEO THERAPEUTICS INC | $4.32M | 0.85% | 928,593 | 0 | 0.0% | — | Unchanged |
| ALEC | ALECTOR INC | $4.22M | 0.83% | 2,101,068 | 0 | 0.0% | — | Unchanged |
| — | LEONABIO INC | $3.62M | 0.71% | 393,701 | 0 | 0.0% | — | Unchanged |
| CRVS | CORVUS PHARMACEUTICALS INC | $3.46M | 0.68% | 231,585 | 0 | 0.0% | — | Unchanged |
| — | JATT II ACQUISITION CORP | $1.82M | 0.36% | 160,000 | 160,000 | — | — | First reported |
| — | CENTESSA PHARMACEUTICALS | $0 | 0.00% | 0 | -489,849 | -100.0% | -$19.46M | Sold out |
| — | KALVISTA PHARMACEUTICALS | $0 | 0.00% | 0 | -897,681 | -100.0% | -$18.07M | Sold out |
| MAZE | MAZE THERAPEUTICS INC | $0 | 0.00% | 0 | -200,000 | -100.0% | -$5.97M | Sold out |